GL1X · GenesisL1 explorer

MolNFT v1 · #98172 · protein

Crystallographic study of multi-drug resistant HIV-1 protease lopinavir complex: mechanism of drug recognition and resistance

4L1A · MDR769 HIV-1 protease: “Crystallographic study of multi-drug resistant HIV-1 protease lopinavir complex: mechanism of drug…”. X-ray diffraction, 1 ligand (AB1), 1 pocket (best druggability 0.62). MolNFT v1 #98172 on GenesisL1: 3D…

PDB
4L1A
Type
protein
Length
198 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
MDR769 HIV-1 protease
UniProt
Q000H7
Ligands
AB1
Pockets
1 · best druggability 0.62

Structure

x-ray diffraction · 2 distinct chains · 6% helix, 54% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AMDR769 HIV-1 proteaseprotein996% helix, 54% strandQ000H7
BMDR769 HIV-1 proteaseprotein996% helix, 54% strandQ000H7

Ligands and binding sites

  • AB1 · N-{1-benzyl-4-[2-(2,6-dimethyl-phenoxy)-acetylamino]-3-hydroxy-5-phenyl-pentyl}-3-methyl-2-(2-oxo-tetrahydro-pyrimidin-1-yl)-butyramide · ligand · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15910.620.7441AB1

Interfaces

1 interface between chains.

  • A–B · 1476 Ų buried · 44 hydrogen bonds · protein-protein

Compared structures

  • 4L1A · Crystallographic study of multi-drug resistant HIV-1 protease Lopinavir complex… · the same entry in another collection · chain B against B, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.